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Wnt-mediated signals are involved in many impor-
tant steps in mammalian regeneration. In multiple
cell types, the R-spondin (Rspo) family of secreted
proteins potently activates the canonical Wnt/b-cat-
enin pathway. Here, we identify Rspo1 as a mediator
of skeletal muscle tissue repair. First, we show that
deletion of Rspo1 results in global alteration of mus-
cle regeneration kinetics following acute injury. We
find that muscle progenitor cells lacking Rspo1
show delayed differentiation due to reduced activa-
tion of Wnt/b-catenin target genes. Furthermore,
muscle cells lacking Rspo1 have a fusion phenotype
leading to larger myotubes containing supernumer-
ary nuclei both in vitro and in vivo. The increase in
muscle fusion was dependent on downregulation of
Wnt/b-catenin and upregulation of non-canonical
Wnt7a/Fzd7/Rac1 signaling. We conclude that recip-
rocal control of antagonistic Wnt signaling pathways
by Rspo1 in muscle stem cell progeny is a key step
ensuring normal tissue architecture restoration
following acute damage.
INTRODUCTION
Adult muscle stem cells, called satellite cells (MuSCs), located
around the differentiated myofibers exist in a quiescent state
and are readily identified through the expression of the paired-
box transcription factor Pax7 (Seale et al., 2000). Following injury
to the host myofibers, they become activated and proliferate to
give rise to muscle progenitor cells expressing the myogenic
regulatory factors MyoD and Myogenin that act to promote dif-2320 Cell Reports 18, 2320–2330, March 7, 2017 Crown Copyright ª
This is an open access article under the CC BY license (http://creativeferentiation (Charge´ and Rudnicki, 2004). Differentiating myo-
cytes will fuse together to form myotubes that eventually mature
into new myofibers. Myocyte differentiation and fusion pro-
cesses are highly regulated (Abmayr and Pavlath, 2012).
Abnormal fusion can lead to the formation of giant, albeit disor-
ganized, myofibers (Charrin et al., 2013) while a reduction in my-
ocyte fusion potentially results in smaller muscles with myofibers
containing fewer nuclei (Horsley et al., 2003). This is exemplified
in skeletal muscle pathologies such as Duchennemuscle dystro-
phy (DMD). In dystrophic muscles, the continuous regeneration
process leads to the formation of abnormal fibers, termed
branched or split fibers, which are more prone to damage during
contraction (Chan et al., 2007), lack force generation, and
contribute to the disease progression (Head, 2010).
The Wnt signaling pathways are crucial regulators of myogen-
esis (von Maltzahn et al., 2012). The canonical Wnt/b-catenin
pathway is required for muscle progenitor cell differentiation
and plays a key role in skeletal muscle development (Borello
et al., 2006; Anakwe et al., 2003) and repair following injury (Brack
et al., 2009; Parisi et al., 2015). The non-canonical Wnt7a/Fzd7
signaling pathway plays a central role in three other aspects of
muscle regeneration, namely, promoting the symmetric expan-
sion of satellite stem cells through the planar cell polarity (PCP)
pathway (Le Grand et al., 2009), enhancingMuSCs andmyoblast
migration (Bentzinger et al., 2014), and activating the anabolic
Akt growth pathway in myofibers (von Maltzahn et al., 2011).
In many tissues, the activation of both canonical (Carmon
et al., 2011) and non-canonical (Glinka et al., 2011) Wnt
pathways is regulated by R-spondins. The R-spondin family of
secreted proteins is comprised of four members (RSPO1–
RSPO4) (de Lau et al., 2012). Each R-spondin has its own
expression pattern and properties. R-spondins interact with
leucine-rich repeat-containing G protein-coupled receptors
(LGR) (de Lau et al., 2011) and potentiate Wnt signaling path-
ways by neutralizing the E3 ligases RNF43 and ZNRF3 that2017
commons.org/licenses/by/4.0/).
Figure 1. R-spondin1 Is Expressed in MuSCs
and Primary Myocytes
(A) RSPO1 (red) and PAX7 (green) immunolocaliza-
tion in MuSCs on single myofibers.
(B) MYOGENIN (red) and RSPO1 (green) im-
munolocalization in 24 hr-differentiating myocytes.
(C) Occupancy of PAX7-Flag proteins at the pro-
moters ofMyf5,Rspo1, andGapdh (control) genes in
primary myoblasts. The input represents the relative
enrichment of PAX7-Flag proteins compared to the
controls (IgG and Flag-Mock). Rspo1 (1) and Rspo1
(2) indicate two different pairs of primers. Nuclei are
stained with Hoechst (blue). Scale bars, 20 mm.normally act to remove Wnt receptors from the surfaces of stem
cells (Koo et al., 2012; Hao et al., 2012).
A number of studies reported the essential roles played by
R-spondins during both embryonic development and adult tissue
homeostasis or repair. For example, Rspo1 is required for female
sexual development and Rspo1-nullmice showmasculinized go-
nads (Parma et al., 2006; Chassot et al., 2008). In adult tissues,
RSPO1 promotes growth of the intestinal epithelium (Kim et al.,
2005), is a pancreatic beta-cell growth factor (Wong et al., 2010),
and drives liver stem cell expansion (Huch et al., 2013). To date,
the role of R-spondins in regenerative myogenesis remains un-
clear. Rspo1, Rspo2, and Rspo3 were shown to be expressed
by proliferating primary myoblasts, but only Rpso1 and Rspo3
were upregulated by the differentiation program (Han et al.,
2011). A recent report documented that Rspo1 transcription was
strongly upregulated in primary myoblasts overexpressing Pax7Cell(Soleimani et al., 2012). We hence aimed to
identify the functionofRspo1 in steady-state
muscle as well as during regeneration.
RESULTS
Muscle Satellite Cells Express the
Pax7 Target Gene Rspo1
To profile Rspo1 expression in adult
MuSCs, we performed immunocytochem-
ical analysis for PAX7 and RSPO1 on myo-
fibers isolated from extensor digitorum
longus (EDL)muscles.We found that quies-
centMuSCs expressedRSPO1 protein and
that its expression increased following their
activation (24 hr after isolation) (Figure 1A).
Of note, RSPO1 was mostly cytoplasmic
in quiescent MuSCs but appeared both in
the cytoplasm and nucleus in activated
MuSCs. In vitro analysis confirmed the
expression of RSPO1 by differentiating pri-
mary muscle cells (Figure 1B).
We next tested if Rspo1 is a direct target
of Pax7 in adult myogenic cells. To this end,
we determined, by chromatin immunopre-
cipitation (ChIP), whether PAX7 proteins
interact with a putative binding site local-
ized 35 kb upstream of Rspo1 gene identi-fied by ChIP coupled with deep sequencing (Soleimani et al.,
2012). ChIP assays were performed using primary myogenic
cell cultures expressing Pax7-Flag. They demonstrated that
PAX7 proteins were bound to the Rspo1 gene upstream regula-
tory region as well as to the positive controls (Myf5 111 kb and
57 kb enhancer regions), as relative to a mock IP and to the
negative controls (Figure 1C) in muscle progenitor cells.
Rspo1 Is Not Required for Muscle Tissue Formation
We next investigated whether Rspo1 plays a role in the adult
skeletal muscle tissue using Rspo1 loss-of-function mice (Chas-
sot et al., 2008). We did not observe any phenotypic difference in
skeletal muscle histology (Figure S1A) and weights (Figure S1B)
of young adult (8-week-old) Rspo1-null compared to control
mice (controls are wild-type and Rspo1-heterozygous mice). In
tibialis anterior (TA) muscles, loss of Rspo1 expression did notReports 18, 2320–2330, March 7, 2017 2321
alter the number of myofibers (Figure S1C), their size (Fig-
ure S1D), or cross-sectional area (CSA) (Figure S1E). In agree-
ment with these findings, quantification of the number of myonu-
clei per myofiber (Figure S1F) and of the entire muscle CSA
(Figure S1G) did not show any significant difference between
the two genotypes. Furthermore, Rspo1-null and control animals
showed similar number of Pax7-expressing MuSCs in cryosec-
tions of TA (Figure S1H), soleus, gastrocnemius, and triceps
(data not shown). Immunocytochemical analysis for PAX7 and
RSPO1 on Rspo1-null myofibers validated the specificity of the
Rspo1 antibody (Figure S1I). These results show that Rspo1 is
not required for myofiber formation, cellular organization, nor
for the establishment of the MuSC population.
Rspo1 Regulates Skeletal Muscle Tissue Regeneration
To investigate the role of Rspo1 in skeletal muscle regeneration,
we injured TAmuscles of control andRspo1-nullmice with cardi-
otoxin injection. During the early phase of tissue regeneration at
4 days post-injury (d.p.i.) (Figure 2A), the number of Pax7+ pro-
genitors was similar between control and Rspo1-null muscles
(Figure 2B), but Rspo1-null muscles contained decreased
numbers of Myogenin+-differentiating cells (Figure 2C) and of
nuclei incorporated into myotubes (Figure 2D). This suggests a
delay in the differentiation process. Later, at 7 d.p.i., (Figure 2E),
newly formed myofibers were of a similar caliber in both geno-
types (Figure 2F), but the number of Myogenin+ cells inside myo-
fibers was increased inRspo1-nullmuscles (Figure 2G), suggest-
ing a compensatory enhancement of fusion in Rspo1-null
muscles. At this time point, the number of Pax7+ progenitors re-
mained similar between Rspo1-null and control muscles (Fig-
ure 2H). In this experimental setup, we did not observe any signif-
icant differences between male and female animals (Figure S2).
We next analyzed the morphology and cellular composition of
fully regeneratedmuscles 62 d.p.i. (Figure 2I). Strikingly, regener-
atedRspo1-nullmuscleswere larger (Figures 2J) andheavier (Fig-
ure 2K) compared to control muscles. Regenerated Rspo1-null
muscles were composed of larger myofibers (Figures 2L and
2M) containing a higher number of myonuclei (Figures 2N and
2O). Interestingly, quantification of sub-laminar MuSCs did not
show any difference between both genotypes at 62 d.p.i.. To
determine if improved muscle cell fusion resulted in functional
changes, we compared the contractile properties of regenerated
muscle in situ using an index of fatigue resistance (Figure 2P) and
specificmaximal force, amarkerof forceproductioncapacity (Fig-
ure 2Q). These experiments indicate that regenerated Rspo1-null
muscles, while composed of larger myofibers containing more
myonuclei, are functional, because we found no reductions in
the performed assays. Taken together, our results suggest that
Rspo1 is required for the proper timing of myogenic progenitor
cells differentiation following injury and inhibits fusion in vivo.
Rspo1 Does Not Influence Primary Myoblasts
Proliferation
To further analyze thebehaviorofmusclecellsdevoidofRspo1, we
culturedprimarymyoblastsexpanded fromMuSCssortedbymag-
netic-activated cell sorting (MACS).Rspo1-null cells showed stan-
dard morphology and expressed the muscle progenitor marker
M-CADHERIN (Figure S3A) (Cornelison and Wold, 1997). While2322 Cell Reports 18, 2320–2330, March 7, 2017proliferating, control and Rspo1-null myoblasts expressed similar
levels of Pax7 transcript (Figure S2C) and more than 98% of the
cells expressed PAX7 protein (Figure S3B). Immunostainings for
the mitosis marker phospho-HIST1H3 (Figure S3D) and the cell-
cycle marker MKI67 (Figure S3E) did not reveal any differences in
proliferation betweenRspo1 null and control cells. Likewise, quan-
tification of the proportion of cells engaged in S-phase by 5-ethy-
nyl-20-deoxyuridine (EdU) incorporation assay (Figure S3F) did
not show any difference between control and Rspo1-null cells in
either high serum (Figure S3G) or low serum (Figure S3H) culture
conditions. Our results demonstrate that Rspo1 is not required
for myogenic progenitor expansion from MuSCs.
Rspo1 Positively Controls Muscle Cell Differentiation
through the Canonical Wnt/b-Catenin Pathway
We further induced Rspo1-null and control primary myoblasts to
differentiate in vitro and quantified the number of myocytes ex-
pressing MYOGENIN at different time points (Figure 3A). Similar
to our in vivo observations, Rspo1-null myocytes showed a
significant differentiation delay compensated after 2 days in dif-
ferentiation medium (Figure 3B). To understand the molecular
mechanisms regulated by Rspo1 in muscle cells, we analyzed
gene expression of Rspo1-null and control myocytes using Affy-
metrix microarrays. The expression data identified downregula-
tion of a large number of genes implicated in skeletal myogenesis
in Rspo1-null cells (Figure 3C). The Ingenuity Pathway Analysis
(IPA) software identifiedMyoD as themost prominent downregu-
lated upstream regulator (Figure 3D). We further validated the
downregulation of MyoD expression by qRT-PCR (Figure 3E).
The transcriptome analysis further highlighted a downregula-
tion in the expression of a set of genes implicated in canonical
Wnt pathway in Rspo1-null cells (Figure 3F). We validated
reduced expression levels of the b-catenin target genes Fst (Fig-
ure 3G) and Bmp2 (Figure 3H) by qRT-PCR. We then investi-
gated if Wnt/b-catenin target genes expressions could be
induced in Rspo1-null cells following exogenous ligand stimula-
tion. Following WNT3A protein treatment, control myocytes ex-
hibited elevated expression of the b-catenin responsive genes
Fst, Gja5, and Tgfb2 (Figures 3I, 3K, and 3M) (Rudolf et al.,
2016). In contrast, Rspo1-null myocytes did not respond
to exogenous WNT3A stimulation (Figures 3J, 3L, and 3N).
Quantification of active-b-CATENIN proteins in nuclear and
cytoplasmic fractions (Figure 3O) showed that b-CATENIN was
de-phosphorylated and translocated to the nuclei following
WNT3A stimulation only in control cells (Figure 3P). Because
activation of Wnt/b-catenin signaling is required in muscle
progenitor cells to support differentiation (Rudolf et al., 2016),
we hypothesized that a lack of b-CATENIN activation in
Rspo1-null myocytes could explain the observed delay in differ-
entiation. To stabilize b-CATENIN proteins in muscle cells,
independently of the extracellular ligands, we used the small
molecule CHIR99021 to inhibit GSK3 and subsequently the
b-catenin destruction complex. Quantification of the number of
differentiated cells showed that CHIR99021-mediated activation
of the Wnt/b-catenin pathway, which acts downstream of the re-
ceptor, restored a control state of differentiation in Rspo1-null
cells (Figure 3Q). Moreover, treatment of Rspo1-null myoblasts
with CHIR99021 rescued the expression of the b-catenin target
Figure 2. Rspo1-null Muscles Show Enhanced Regeneration Caused by a Delay of Muscle Progenitor Cell Differentiation and an Improved
Fusion
(A) LAMININ (red) and MYOGENIN (green) immunolocalization in TA muscles at 4 d.p.i.
(B–D) Quantification of the number of PAX7-positive cells (B), MYOGENIN-positive cells (C), and myonuclei (D) per myofiber 4 d.p.i.
(E) DYSTROPHIN (red) and MYOGENIN (green) immunolocalization at 7 d.p.i.
(F) Mean CSA of myofibers in TA muscles at 7 d.p.i.
(G) Quantification of the number of MYOGENIN-positive cells inside the myofibers showing a higher proportion of fused nuclei at 7 d.p.i. in Rspo1-null mice.
(H) Quantification of the number of PAX7-positive cells per myofiber at 7 d.p.i.
(I and J) LAMININ (red) immunolocalization on muscle sections at 62 d.p.i. (I) and a whole cross-section of regenerated 62 d.p.i. muscles (J). Images are virtual
slides automatically assembled by the Axio Scan.Z1 microscope.
(K and L) Quantification of TA muscle weights (K) and mean CSA (L) at 62 d.p.i.
(M and N) Number of myofibers per surface unit (N) and of nuclei per myofiber (M) at 62 d.p.i.
(O) Distribution of the percentage of myofibers depending on their nuclear number at 62 d.p.i.
(P and Q) Fatigue resistance index (P) and specific maximal force (Q) of 62 d.p.i. muscles. Nuclei are stained with Hoechst (blue). Scale bars, 50 mm (A and E);
35 mm (I); 150 mm (J). Error bars indicate SD. *p value < 0.05; **p value < 0.01.genes (Figure S4). Taken together, our data suggest that RSPO1
is required for the activation of the canonical Wnt pathway during
myogenic differentiation.
Rspo1 Limits Cell Fusion
Wenext investigatedmuscle cell fusion inRspo1-null and control
primary myocytes. After 4 days in differentiation media, controlmyocytes fused and generated both small and large myotubes,
while Rspo1-null cells generated much larger syncytia (Fig-
ure 4A). Consequently, the number of myotubes per surface
was reduced in Rspo1-null cultures (Figure 4B), and the average
diameter of Rspo1-null myotubes was higher compared to con-
trol myotubes (Figure 4C). Graphical distribution of myotube size
further demonstrated that this increase was homogeneous andCell Reports 18, 2320–2330, March 7, 2017 2323
(legend on next page)
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not due to the appearance of a specific sub-population (Fig-
ure 4D). Importantly, while the percentage of nuclei that under-
went fusion was similar in cultures of both genotypes (Figure 4E),
we observed a significantly higher proportion of myotubes con-
taining more than seven nuclei in Rspo1-null cultures (Figure 4F).
We next treated myocytes after 24 hr of differentiation with
CHIR99021 and let them fuse for 2 more days in vitro.
CHIR99021 treatment completely abolished muscle cell fusion
of both control and Rspo1-null cells (Figures 4G and 4H). These
observations indicate that even though canonical Wnt signaling
is required for proper commitment to the differentiated state, it
is inhibitory for myocyte fusion. Our results indicate that Rspo1
negatively regulates muscle cell fusion and that its absence
leads to the generation of larger myotubes containing more
nuclei.
Rspo1 Negatively Regulates the Non-canonical Wnt7a/
Fzd7 Pathway
Our data suggest that Rspo1 has contradictory roles in muscle
progenitor cell differentiation and fusion. We thus hypothesized
that Rspo1 depletion could also impact the non-canonical Wnt
pathway. It is known that WNT7A stimulates the migration of
MuSCs and primary myoblasts through RAC1 activation (Bent-
zinger et al., 2014). We thus validated that WNT7A stimulation
of wild-type differentiating myocytes results in enhancement of
muscle fusion, as shown by increasedmyotube size (Figure S5A)
and a higher number of myonuclei (Figures S5B and S5C). As
such, upregulation of non-canonical Wnt7a signaling could
explain the increased fusion we observed in Rspo1-null muscle
cells.
To test this hypothesis, we performed scratch-wound assays
(Figure 5A) and observed that Rspo1 deficiency increased myo-
cyte migration (Figure 5B). Time-lapse imaging on single myofib-
ers (Otto et al., 2011) showed that Rspo1-null MuSCs has lower
velocity than control cells (Figure 5C). Interestingly, time-lapse
imaging of myocytes in wound assays revealed that Rspo1 defi-
ciency significantly increased both the mean velocity (Figure 5D)
and the minimum speed (Figure 5E) of migrating cells. These
results indicate that Rspo1 inhibits the motility of myogenic pro-
genitor cells, but not MuSCs, during directed migration.
The major receptor of WNT7A in myogenic cells is FRIZZLED7
(FZD7) (Le Grand et al., 2009) that accumulates at the peripheryFigure 3. Rspo1-null Cells Have a Differentiation Defect Due to an Imp
(A) MYOGENIN (red) immunolocalization in control and Rspo1-null myocytes. Sc
(B) Quantification of differentiated cells.
(C) List of genes involved in muscle development and regulated by Rspo1 dep
myocytes.
(D) Upstream Regulators analysis of Rspo1-null myocytes transcriptome.
(E) qPCR analysis of MyoD expression.
(F) List of Rspo1-regulated genes involved in canonical Wnt pathway.
(G and H) qPCR analysis of Fst (G) and (H) Bmp2 expression levels in differentia
(I, K, and M) Increased expression of Fst (I), Gja5 (K), and Tgfb2 (M) following WN
(J, L, and N) Unchanged expression of Fst (J), Gja5 (L), and Tgfb2 (N) following W
(O and P) Western blot (O) and quantification (P) of active b-CATENIN showing a d
treated with WNT3A.
(Q) Quantification of differentiated cells after a WNT3A- or a CHIR99021-treatm
in Rspo1-null cells restores a control state of differentiation. Nuclei are stained
***p value < 0.001.of moving cells during migration (Bentzinger et al., 2014). Immu-
nolocalization of FZD7 in primary myocytes demonstrated that
while few cells show FZD7 accumulation in control and
WNT3A-treated conditions, FZD7 staining appeared polarized
in both WNT7A-treated cells and Rspo1-null cells (2-fold in-
crease) (Figure 5F). We also observed a slight increase in Fzd7
gene expression in Rspo1-null cells (Figure 5G). Altogether,
these results suggest an enhancement of non-canonical
Wnt7a/Fzd7 signaling in Rspo1-null cells.
We next transfected both control and Rspo1-null cells with
small interfering (siRNA) directed against Fzd7 (Figure 5G). We
quantified the number of migrating cells in scratch wound assays
(Figure 5H) and observed that siFzd7 treatment decreased cell
migration in both control and Rspo1 null cells. Importantly,
Rspo1-null cells treated with siFzd7 migrated at a rate similar
to control cells, indicating that the increase in cell motility
observed in Rspo1-null cells was related to an increase in
Wnt7a/Fzd7 signaling (Figure 5I). We then differentiated control
and Rspo1-null myocytes in control and Fzd7 silencing condi-
tions or in the presence of RAC1 inhibitor EHop-016 (Mon-
talvo-Ortiz et al., 2012) (Figure 5J). Strikingly, treatment of
Rspo1-null cells with either siFzd7 or EHop-16 restored the pro-
portion of large myotubes containingmore than seven nuclei to a
percentage similar to untreated control cells (Figure 5K). Inter-
estingly, siFzd7 treatment resulted in a small reduction in fusion
index in both controls and Rspo1-null cells (Figure 5L).
In summary, our results demonstrate that Rspo1 negatively
regulates muscle cell migration and fusion by dampening non-
canonical Wnt7a/Fzd7/Rac1 pathway. Our data suggest that,
in MuSC progeny, Rspo1 integrates antagonistic Wnt pathways
for fine-tuning of muscle architecture during tissue repair.
DISCUSSION
In most mammalian tissues, the R-spondin family of secreted
proteins positively regulates the canonical Wnt signaling
pathway. Canonical Wnt signaling plays an important role in
adult muscle regeneration by allowing for the timely differentia-
tion of MuSC descendants during tissue repair (Figeac and Zam-
mit, 2015; Rudolf et al., 2016). Here, we show that the absence of
Rspo1 expression significantly affects myogenic progenitor cell
differentiation both in vitro and in vivo and is associated with aaired Activation of the Wnt/b-Catenin Pathway
ale bar, 50 mm.
ending on their fold change in gene expression in Rspo1-null versus control
ted Rspo1-null and control myocytes.
T3A treatment in control cells.
NT3A treatment in Rspo1-null cells.
ecrease in b-CATENIN protein levels in nuclei of Rspo1-null primary myoblasts
ent, demonstrating that the forced-activation of the Wnt/b-catenin pathway
with Hoechst (blue). Error bars indicate SD. *p value < 0.05; **p value < 0.01;
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Figure 4. Rspo1-null Cells Show Enhanced Fusion
(A) MYHC immunolocalization (red) of myotubes after 4 days of differentiation.
(B) Quantification of the number of myotubes per surface.
(C) Mean diameter of myotubes showing that Rspo1-null myotubes are 30% bigger than control myotubes.
(D) Distribution of the percentage of myotubes depending on their diameter.
(E) Quantification of the number of fused cells normalized to the total number of cells.
(F) Quantification of the number of nuclei per myotube.
(G) Myocytes were treated with CHIR099021 24 hr after induction of differentiation. MYHC immunolocalization (red) in myotubes after 4 days of differentiation.
(H) Quantification of the number of nuclei per cell. Activation of canonical Wnt signaling by CHIR99021 completely blocks muscle cell fusion. Nuclei are stained
with Hoechst (blue). Scale bars, 50 mm. Error bars indicate SD. *p value < 0.05; **p value < 0.01; ***p value < 0.00.defect in canonical Wnt/b-catenin activation. These data are
consistent with previous reports demonstrating that RSPO1 is
a regulator of tissue-resident stem cells such as the mammary
gland (Cai et al., 2014), the skin (Li et al., 2016), or the intestine
(de Lau et al., 2011).
Our results show that Rspo1 is dispensable for muscle devel-
opment. This is also the case for other members of the family,
and this outcome could be explained through compensation.
In contrast, we show that Rspo1 is essential for adult muscle
regeneration. Following injury, Rspo1-null muscle progenitor2326 Cell Reports 18, 2320–2330, March 7, 2017cells show a transient delay in differentiation, but Rspo1-null
muscles go on to regenerate efficiently and are even composed
of bigger myofibers containing more myonuclei. This increase in
fusion is due to a concomitant downregulation of canonical Wnt/
b-catenin signaling and upregulation of non-canonical Wnt7a/
Fzd7/Rac1 signaling pathways inmuscle progenitor cells. There-
fore, Rspo1-null muscle cells migrated faster and fused with a
higher efficiency compared to wild-type cells, and these pheno-
types were normalized by Fzd7 silencing or RAC1 inhibition.
Importantly, while it has been shown that RSPO3 can activate
Figure 5. Rspo1 Depletion Potentiates Wnt7a/Fzd7/Rac1 Signaling
(A) Phalloidin (green) staining of myocytes 24 hr after scratching confluent-state cells. White bars show the limits of the scratch.
(B) Quantification of the number of cells in the scar 24 hr after the scratch showing increases migration of Rspo1-null myocytes.
(C) Quantification of the mean speed of MuSCs on single myofiber.
(D and E) Quantification of the mean speed (D) and of the minimum speed (E) of myocytes.
(F) FZD7 (green) immunolocalization in myocytes treated by WNT3A and WNT7A recombinant proteins. Asterisks represent FZD7 proteins located at the cell
membrane. Percentages of cells with polarized FZD7 staining are indicated on the right.
(G) qPCR analysis of Fzd7 expression in myocytes confirming siRNA efficiency.
(H) Myocytes 24 hr after scratching confluent-state cells upon siFzd7 treatment. White bars show the limits of the scratch.
(I) Quantification of the number of migrating cells shows a decreased migration upon Fzd7 silencing.
(J) MYHC (red) immunolocalization in myotubes treated with siFzd7 or EHop16.
(K) Quantification of the number of myotubes with more than seven nuclei.
(L) Fusion index of myotubes upon siFzd7 treatment. Nuclei are stained with Hoechst (blue). Scale bars, 50 mm (A, H, and J); 20 mm (F). *p value < 0.05; **p value <
0.01; ***p value < 0.001; ****p value < 0.0001. Error bars correspond to SD.the non-canonical Wnt pathway during Xenopus embryonic
development (Ohkawara et al., 2011), the impact of R-spondins
on non-canonical Wnt pathways has not been previously
demonstrated in adult mammalian cells. Further work would be
to investigate the role of R-spondin proteins in controlling non-
canonical Wnt pathways in other adult stem cells.Activation of the Wnt7a/PCP pathway in MuSCs induces
their symmetrical expansion. As such, Wnt7a overexpression
enhances muscle regeneration and increases MuSC numbers
(Le Grand et al., 2009). In contrast, while we observed that
Rspo1 deficiency resulted in over-activation of Wnt7a/Fzd7/
Rac1 pathway in differentiating myocytes, we did not find anyCell Reports 18, 2320–2330, March 7, 2017 2327
differences in the number of Pax7-expressing myogenic progen-
itors during muscle regeneration or in the MuSCs pool after
regeneration is finished. Our data suggest that RSPO1 does
not influence the Wnt/PCP pathway in MuSC. We hypothesize
that this stage-specific requirement for RSPO1 action is related
to the fact that canonical Wnt/b-catenin signaling is inactive in
MuSC, but activated in differentiating myogenic progenitor cells
(Rudolf et al., 2016). We propose that Rspo1 controls the antag-
onistic balance between canonical and non-canonical Wnt path-
ways specifically in differentiating muscle cells.
Both canonical and non-canonical Wnt signaling induce
distinct cellular and molecular processes but share several
core components. Thus, the exclusive activation of a Wnt
pathway is possible by the selective interaction between specific
ligands and receptors. More precisely, it has been shown that
WNT5A can inhibit or activate b-catenin signaling depending
on the presence of specific Frizzled receptors at the membrane
(Mikels and Nusse, 2006). It is also well documented that canon-
ical and non-canonical Wnt ligands can compete for the activa-
tion of their selective pathways. Non-canonical WNT5A can
antagonize Wnt/b-catenin activation in Xenopus (Larabell et al.,
1997) and in mammalian hematopoietic stem cells (Nemeth
et al., 2007). The increase in non-canonical Wnt signaling
observed in Rspo1-null muscle cells could then be related to a
change in the composition of surface receptors. We propose
that Rspo1 has a role in maintaining the ‘‘canonical’’ Frizzled
receptors at the surface of muscle cells, and its absence can
lead to a preferential increase in the availability of non-canonical
Frizzled receptors. The increase in FZD7 membrane expression
in Rspo1-null cells may start answering this question, but further
work will be dedicated to exploring the expression pattern of the
different Frizzled receptors expressed at the surface of MuSCs
and their descendants, their dynamics duringmyogenic commit-
ment, and myotube formation.
Rspo1-deficient muscles can regenerate efficiently and have
an increase in nuclear content. The generation of larger myofib-
ers containing fewer myonuclei has been described as patholog-
ical because it can perturb muscle homeostasis and function. An
example is the hyper-muscularMyostatin nullmice, in which fiber
enlargement is not accompanied by a commensurate increase in
nuclear content and is postulated to lead to compromised phys-
iological performance in terms of force generation and fatigability
(Amthor et al., 2007; Mouisel et al., 2014). A number of studies
have suggested that there is a finite nuclear to cytoplasmic vol-
ume that supports normal cellular function that when exceeded,
as in the case of Myostatin null muscle, leads to functional
impairment (Matsakas et al., 2013). Interestingly, our analysis
of the contractile properties of regenerated Rspo1-null muscles
indicated that, while containing more nuclei, the regenerated
myofibers were functional. We thus suggest that RSPO1 protein
could serve as a therapeutic treatment in muscle pathologies
that show aberrant or elevated muscle progenitor fusion.EXPERIMENTAL PROCEDURES
Mice
Experimental animal protocols were performed in accordance with the guide-
lines of the French Veterinary Department and approved by the University2328 Cell Reports 18, 2320–2330, March 7, 2017Paris-Descartes Ethical Committee for Animal Experimentation. All experi-
ments were performed in 6- to 9-week-old mice. Our animals are on
C57B6N/SV129 genetic background. Rspo1-null mice genotyping has been
described previously (Chassot et al., 2008).
Muscle Stem Cells Isolation and Primary Myoblasts Culture
Skeletal muscles of mice were dissected (quadriceps, TA, EDL, gastrocne-
mius, soleus, gluteus) and transferred to a sterile Petri dish on ice. Muscles
were incubated in a solution of 1.5 U/mL of collagenase B, 2.4 U/mL of Dispa-
seII, and 2 M of CaCl2 for 45 min at 37
C with periodic mechanical digestion.
Fetal bovine serum was added to stop the digestion. After centrifugation,
pellet was resuspended in growth medium consisting of Ham’s F10 (Life
Technologies) with 20% FBS (Eurobio), 1% Pen/Strep (Life Technologies),
and 2.5 ng/mL basicFGF (R&D Systems). Satellite cells were then purified using
MACS cell separation system, according to the manufacturer’s protocol. Sat-
ellite cells were then allowed to proliferate and give rise to primary myoblasts
after two passages. If needed, primary myoblasts were differentiated using a
differentiation medium composed of DMEM (GIBCO) with 2% horse serum
(GIBCO), and 1% Pen/Strep (GIBCO). Cells were treated with 50 ng/mL of re-
combinant WNT3A and/or WNT3A proteins (R&D Systems) for a minimum of
24 hr or with the RAC1 inhibitor eHop-016 (Sigma) at 1.5 mM for 8 hr.
Immunostaining and EdU Incorporation on Primary Myoblasts
Primary myoblasts were fixed for 8 min with 4% PFA in PBS then incubated
with 0.2% Triton in PBS for 20 min at room temperature. Cells were incubated
with primary antibodies during 1 hr at room temperature, followed by PBS
washes and a 1 hr incubation with the secondary antibodies. Nuclei were
stained with Hoechst. Primary antibodies used were R-spondin1 (Sigma),
Phospho-HIST1H3 (Cell Signaling), Pax7 (Santa Cruz), Myogenin (Santa
Cruz), M-Cadherin (BD Biosciences), MYHC (R&D Systems), and MKI67
(Santa Cruz). EdU incorporation was performed with Click-iT EdU Imaging
Kits from Invitrogen, according to the manufacturer’s protocol. Cells were
incubated with EdU for 1 hr at 37C.
Scratch Assay
Cells were treated with 10 mg/mL of Mitomycin-C (Sigma) for 8 hr before
scratching the monolayer of cells in a straight line. Plates were washed few
times with PBS and primary myoblasts were incubated in growth medium
for 24 hr at 37C. If needed, WNT7A recombinant proteins (100 ng/mL from
R&D Systems) were added in the culture medium. Cells were then fixed with
4% PFA-PBS, and nuclei were stained with Hoechst. The numbers of nuclei
in the scar were counted manually.
RNA Interference
Primary cells were seeded in collagen-coated plate in growth medium without
Pen/Strep. siRNA transfection was performed using Lipofectamine 2000 and
OptiMEM according to the manufacturer’s protocol. Both siFzd7 and siControl
(Ambion) were used at a 50-mM concentration.
Live Imaging
Cell imaging was performed on a microscope (Zeiss Axio Observer.Z1) with
103 objective under 5% CO2 at 37
C in differentiation media. Image acquisi-
tion was performed with Metamorph software (Molecular Devices) with time
points acquired every 8 min over 24 hr. Velocity was calculated with ImageJ
software. The minimum velocity is defined as the lowest velocity obtained by
cells during the tracking period.
qPCR
RNA was isolated either by RNeasy Mini Plus Kit (QIAGEN) or by TRIzol Re-
agent followed by a DNase treatment (Life Technologies). The reverse tran-
scription was performed with 100 ng of RNA using the high-capacity cDNA
Reverse Transcription kit (Applied Biosystems). Transcript levels were deter-
mined by LightCycler 480 Real-Time PCR System (Roche) using SYBR green
I Master (Roche). The melting curves were checked for each experiment, and
the primers efficiency was calculated by serial sample dilution. Targeted gene
expressions were normalized by cyclophilin reference gene. Sequences of
primers used are given in the Supplemental Experimental Procedures.
Image Acquisition and Quantitative Analysis
Image acquisitions were performed at the Cochin Institute and the ICM
Imaging Facilities in Paris. Immunofluorescent stainings were analyzed with
an Olympus BX63F microscope, Zeiss Axio Observer.Z1 microscope and
AZ100 Nikon Macroscope from Cochin Institute, and Zeiss Axiovert 200M
microscope and Axio Scan.Z1 microscope from the ICM. We also performed
acquisition on EVOS FL Cell Imaging System microscope. Fluorochromes
Alexa Fluor 488 and Alexa Fluor 546 (Life Technologies) were used. NIS-
Element (Nikon), Metamorph (Molecular Devices), and Photoshop software
(Adobe) were used for image acquisition. Quantifications were performed
with ImageJ software.
Statistical Analysis
Analysis were performed using three to five mice and three to six biological
replicates for cell experiments. Statistical analysis were done using GraphPad
software (Prism) with unpaired two-tailed Student’s t test, the one-way
ANOVA, or the two-way ANOVA. p < 0.05 was considered statistically signifi-
cant. Data were expressed as mean ± SD.
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